Results 51 to 60 of about 382 (79)

Circulating immune and plasma biomarkers of time to HIV rebound in HIV controllers treated with vesatolimod. [PDF]

Front Immunol
Abdel-Mohsen M, Deeks S, Giron L, Hong KY, Goldman A, Zhang L, Huang SSY, Verrill D, Guo S, Selzer L, de Vries CR, Vendrame E, SenGupta D, Wallin JJ, Cai Y.   +14 more
europepmc   +1 more source

Profiles of Globotriaosylsphingosine Analogs and Globotriaosylceramide Isoforms Accumulated in Body Fluids from Various Phenotypic Fabry Patients. [PDF]

Intern Med
Shiga T, Tsukimura T, Kubota T, Togawa T, Sakuraba H.   +4 more
europepmc   +1 more source

Senescence-Induced Lipidome Alterations in Mesenchymal Stromal Cells. [PDF]

J Proteome Res
Ogle ME, Corstvet JL, Vayalakkara RK, Fernández FM, Temenoff JS.   +4 more
europepmc   +1 more source

Let-7f-5p Inhibits PRRSV Replication by Regulating Lipid Metabolic Reprogramming in Infected Cells. [PDF]

Vet Sci
Jiang D, Huang J, Wang X, Zhao G, Li C, Yang L, Meng X, Xu Q.   +7 more
europepmc   +1 more source

Fabry Disease Beyond Storage: The Role of Inflammation in Disease Progression. [PDF]

Int J Mol Sci
Biddeci G, Spinelli G, Colomba P, Duro G, Giacalone I, Di Blasi F.   +5 more
europepmc   +1 more source

HDL-mimetic peptide treatment reverses APOE4-induced transcriptomic and lipidomic alterations in the brain of humanized APOE mice. [PDF]

Alzheimers Dement
Chang A, Kim M, Glittenberg M, Qu W, Li D, Li L.   +5 more
europepmc   +1 more source

Femoral arteriovenous concentration differences reveal metabolomic shifts in peripheral artery disease (PAD): A case-control study. [PDF]

Vasc Med
Ööbik T, Kals J, Eha J, Zilmer M, Kilk K, Paapstel K.   +5 more
europepmc   +1 more source

Dysregulated metabolism of ceramides and glycosphingolipids in Parkinson's disease. [PDF]

J Lipid Res
Peng YF, Chen SJ, Li JL, Lin CH, Kuo CH.
europepmc   +1 more source

Lentivirus-mediated gene therapy for Fabry disease: 5-year End-of-Study results from the Canadian FACTs trial. [PDF]

Clin Transl Med
Khan A, Barber DL, McKillop WM, Rupar CA, Auray-Blais C, Fraser G, Fowler DH, Berger A, Foley R, Keating A, West ML, Medin JA.   +11 more
europepmc   +1 more source

Long-Term Clinical-Pathologic Results of Enzyme Replacement Therapy in Prehypertrophic Fabry Disease Cardiomyopathy. [PDF]

J Am Heart Assoc
Frustaci A, Verardo R, Galea N, Alfarano M, Magnocavallo M, Marchitelli L, Sansone L, Belli M, Cristina M, Frustaci E, Russo MA, Chimenti C.   +11 more
europepmc   +1 more source